Tritoqualine

Tritoqualine
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	R06AX21 (WHO) ;
Identifiers
	IUPAC name 7-amino-4,5,6-triethoxy-3-(4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-3H-isobenzofuran-1-one;
CAS Number	14504-73-5;
PubChem CID	72145;
ChemSpider	65119;
UNII	F4MW5166YH;
CompTox Dashboard (EPA)	DTXSID10864514 ;
Chemical and physical data
Formula	C26H32N2O8
Molar mass	500.548 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCOC1=C(C(=C(C2=C1C(OC2=O)C3C4=C(C5=C(C=C4CCN3C)OCO5)OC)N)OCC)OCC;

Tritoqualine, also known as hypostamine, is an inhibitor of the enzyme histidine decarboxylase and therefore an atypical antihistamine, used for the treatment of urticaria and allergic rhinitis^[1] with no known adverse effects.^{[citation needed]}

References

^ Pradalier A, Hentschel V, Prouzeau S, Legallais D, Lefrancois G (April 2003). "Randomized, placebo controlled study of tritoqualine (hypostamine*) in the treatment of perennial allergic rhinitis". Revue Française d'Allergologie et d'Immunologie Clinique. 43 (3): 175–9. doi:10.1016/S0335-7457(03)00047-9.

This dermatologic drug article is a stub. You can help Wikipedia by expanding it.

This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.